Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-01-19 Purchase |
2022-01-20 4:35 pm |
CymaBay Therapeutics Inc. | CBAY | KIM DENNIS D Chief Medical Officer |
20,000 | $3.04 | $60,800 | 20,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-01-25 Option Award |
2022-01-27 4:57 pm |
N/A 2032-01-24 |
CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance |
75,000 | $0 | 75,000 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:56 pm |
N/A 2032-01-24 |
CymaBay Therapeutics Inc. | CBAY | Dickinson Klara Chief Regulatory Officer |
175,000 | $0 | 175,000 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:56 pm |
N/A 2032-01-24 |
CymaBay Therapeutics Inc. | CBAY | STUART LEWIS J Chief Commercial Officer |
116,667 | $0 | 116,667 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:56 pm |
N/A 2032-01-24 |
CymaBay Therapeutics Inc. | CBAY | KIM DENNIS D Chief Medical Officer |
133,333 | $0 | 133,333 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:55 pm |
N/A 2032-01-24 |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles Chief Scientific Officer |
225,000 | $0 | 225,000 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:55 pm |
N/A 2032-01-24 |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
650,000 | $0 | 650,000 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:54 pm |
N/A 2032-01-24 |
CymaBay Therapeutics Inc. | CBAY | WIGGANS THOMAS G Director |
67,000 | $0 | 67,000 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:54 pm |
N/A 2032-01-24 |
CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director |
67,000 | $0 | 67,000 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:53 pm |
N/A 2032-01-24 |
CymaBay Therapeutics Inc. | CBAY | EMSTER KURT VON Director |
67,000 | $0 | 67,000 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:51 pm |
N/A 2032-01-24 |
CymaBay Therapeutics Inc. | CBAY | Loewy Caroline M Director |
67,000 | $0 | 67,000 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:51 pm |
N/A 2032-01-24 |
CymaBay Therapeutics Inc. | CBAY | Wills Robert James Director |
67,000 | $0 | 67,000 (Direct) |
View |
| 2021-05-17 Option Award |
2021-05-17 6:57 pm |
N/A 2031-05-16 |
CymaBay Therapeutics Inc. | CBAY | KIM DENNIS D Chief Medical Officer |
400,000 | $0 | 400,000 (Direct) |
View |
| 2021-05-10 Option Award |
2021-05-10 5:55 pm |
N/A 2031-05-09 |
CymaBay Therapeutics Inc. | CBAY | STUART LEWIS J Chief Commercial Officer |
360,000 | $0 | 360,000 (Direct) |
View |
Ownership |
2021-05-10 5:47 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | STUART LEWIS J Chief Commercial Officer |
0 | $0 | 1,000 (Direct) |
View |
| 2021-04-05 Option Award |
2021-04-05 5:01 pm |
N/A 2031-04-04 |
CymaBay Therapeutics Inc. | CBAY | WIGGANS THOMAS G Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2021-04-05 Option Award |
2021-04-05 5:00 pm |
N/A 2031-04-04 |
CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2021-01-26 Option Award |
2021-02-01 7:15 pm |
N/A 2031-01-25 |
CymaBay Therapeutics Inc. | CBAY | EMSTER KURT VON Director |
32,000 | $0 | 32,000 (Direct) |
View |
| 2021-01-26 Option Award |
2021-01-28 3:01 pm |
N/A 2031-01-25 |
CymaBay Therapeutics Inc. | CBAY | Wills Robert James Director |
32,000 | $0 | 32,000 (Direct) |
View |
| 2021-01-26 Option Award |
2021-01-28 3:00 pm |
N/A 2031-01-25 |
CymaBay Therapeutics Inc. | CBAY | TRUEX PAUL F Director |
32,000 | $0 | 32,000 (Direct) |
View |
| 2021-01-26 Option Award |
2021-01-28 3:00 pm |
N/A 2031-01-25 |
CymaBay Therapeutics Inc. | CBAY | Loewy Caroline M Director |
32,000 | $0 | 32,000 (Direct) |
View |
| 2021-01-06 Option Award |
2021-01-28 2:59 pm |
N/A 2031-01-25 |
CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance |
42,000 | $0 | 42,000 (Direct) |
View |
| 2021-01-26 Option Award |
2021-01-28 2:58 pm |
N/A 2031-01-25 |
CymaBay Therapeutics Inc. | CBAY | Dickinson Klara Chief Regulatory Officer |
66,500 | $0 | 66,500 (Direct) |
View |
| 2021-01-26 Option Award |
2021-01-28 2:57 pm |
N/A 2031-01-25 |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles Chief Scientific Officer |
112,000 | $0 | 112,000 (Direct) |
View |
| 2021-01-26 Option Award |
2021-01-28 2:56 pm |
N/A 2031-01-25 |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
287,000 | $0 | 287,000 (Direct) |
View |
| 2021-01-26 Option Award |
2021-01-28 2:48 pm |
N/A 2031-01-25 |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
22,167 | $0 | 22,167 (Direct) |
View |
| 2020-10-12 Option Award |
2020-10-14 1:22 pm |
N/A 2030-10-11 |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
275,000 | $0 | 275,000 (Direct) |
View |
Ownership |
2020-08-05 10:00 am |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Avoro Capital Advisors LLC Aghazadeh Behzad 10% Owner |
0 | $0 | 10,300,000 (Indirect) |
View |
| 2020-05-15 Option Award |
2020-06-23 5:10 pm |
N/A 2030-05-14 |
CymaBay Therapeutics Inc. | CBAY | EMSTER KURT VON Director |
49,245 | $0 | 49,245 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-19 5:23 pm |
N/A 2030-05-14 |
CymaBay Therapeutics Inc. | CBAY | von Emster Kurt Director |
49,245 | $0 | 49,245 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-19 5:22 pm |
N/A 2030-05-14 |
CymaBay Therapeutics Inc. | CBAY | TRUEX PAUL F Director |
49,245 | $0 | 49,245 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-19 5:20 pm |
N/A 2030-05-14 |
CymaBay Therapeutics Inc. | CBAY | Loewy Caroline M Director |
49,245 | $0 | 49,245 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-19 5:19 pm |
N/A 2030-05-14 |
CymaBay Therapeutics Inc. | CBAY | Wills Robert James Director |
49,245 | $0 | 49,245 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-19 5:17 pm |
N/A 2030-05-14 |
CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance |
180,564 | $0 | 180,564 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-19 5:16 pm |
N/A 2030-05-14 |
CymaBay Therapeutics Inc. | CBAY | Dickinson Klara See Remarks |
328,299 | $0 | 328,299 (Direct) |
View |